Radium To Treat Cancers – A Bayers Product Approved By European Commission

· TGI - Cancer

European Commission (EC) has granted marketing authorization for Xofigo 1000 kBq/ml, solution for injection (radium Ra 223 dichloride).

It can be used for the treatment of adults with:

The approval of Xofigo is based on data from the pivotal Phase 3 ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) trial.

“Xofigo targets bone metastases, delivering a localized cytotoxic effect to offer patients prolonged survival, making it an exciting advance in the treatment of this cancer.”

Prostate cancer is the second most commonly diagnosed malignancy in men worldwide. In 2008, an estimated 899,000 men were diagnosed with prostate cancer and 258,000 died from the disease worldwide. Prostate cancer is the sixth leading cause of death from cancer in men.

Read more

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: